12:00 AM
Jan 10, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

ISIS-EIF4ERx: Phase II started

Isis began an open-label Phase II trial to evaluate carboplatin and paclitaxel with and without ISIS-EIF4ERx given weekly in about 100 stage...

Read the full 90 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >